An upgrade to Overweight by Piper Jaffray has Sequenom (SQNM) up 7.5% premarket to $4.42, vs....
An upgrade to Overweight by Piper Jaffray has Sequenom (SQNM) up 7.5% premarket to $4.42, vs. Piper's raised price target of $6.50. Of some 10 analysts covering the maker of DNA detection and sequencing equipment, seven are at Buy or Outperform vs. just one rating it at Underperform.
From other sites
at CNBC.com (Dec 3, 2014)
at CNBC.com (Jan 14, 2014)
at CNBC.com (Mar 15, 2013)
at CNBC.com (Apr 25, 2012)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs